CLINICAL_TRIALS
research
· 2026-04-22
Clinical Trial Update: Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder [Phase 1, Phase 2]
Summary
This document reports a Phase 1/2 clinical trial evaluating psilocybin-enhanced psychotherapy for methamphetamine use disorder. The broader condition is listed …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Portland VA Research Foundation, Inc | Conditions: Amphetamine-Related Disorders | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING